admin
A new study of insurance claims in Oregon has set off a firestorm — and for good reason. The peer‑reviewed Research Connections analysis shows rising diagnoses labeled “transgender‑related” and bigger use of puberty blockers and cross‑sex hormones among Oregon youth from 2016 to 2023. Conservatives and commentators are rightly asking what this means for kids, parents, and public policy.
New study reveals higher rates of gender‑affirming care in Oregon
What the Research Connections data show
The study looked at claims for 868,740 insured Oregon adolescents aged 8 to 17. It found 8,480 youth — about 0.98% — with a transgender‑related diagnosis. Among those diagnosed, roughly 23% received some form of medical gender‑affirming care: about 8% got puberty blockers and about 20% received gender‑affirming hormones. The median age at first diagnosis was 14 and the median age to start medical care was 15. The paper also reports that both diagnosis and treatment rose over the 2016–2023 period.
Why Oregon stands out compared with national data
These Oregon figures are higher than recent national claims‑based estimates. The authors point to the state’s more supportive policy environment — including Medicaid coverage for transition‑related care and other state rules that reduce barriers — as likely reasons for greater access. That matters: when a state makes care easier to get and pays for it, more teens will receive it. To be clear, the study uses insurance claims as a proxy for clinical care. Claims data show what was billed and coded, not the full clinical picture or long‑term outcomes.
Parents, safety, and the medical ethics question
This is where the debate turns from numbers to values. Conservatives worry about irreversible procedures, future fertility, and lifelong medical dependence for teens whose bodies are still changing. There are real medical tradeoffs to talk about — and legitimate questions about who decides. Is it parents, doctors, or state policy? Calling for oversight and clarity is not a culture war stunt. It’s asking that children and families get honest information and proper protections before decisions with permanent effects are made.
What should happen next
First, let’s demand transparency. Oregon officials and insurers should publish clear, accountable data tied to outcomes, not just counts of billing codes. Second, policymakers should review consent rules, coverage policies, and clinical guidelines in light of new evidence. Third, we should protect parental rights and require careful medical review for irreversible care. If a state wants to be a national testing ground for controversial treatments of minors, the public should know the full story — and parents must have the last word when their child’s future is on the line.
